candesartan has been researched along with A-V Dissociation in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone was administered orally in a dose of 200 mg/body per day for the initial 7 days followed by 100 mg for the following 21 days (n = 7)." | 1.34 | In vivo electropharmacological effects of amiodarone and candesartan on atria of chronic atrioventricular block dogs. ( Aonuma, K; Matsumoto, M; Nakamura, Y; Sugiyama, A; Takahara, A; Wang, K, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, K | 1 |
| Takahara, A | 1 |
| Nakamura, Y | 1 |
| Aonuma, K | 1 |
| Matsumoto, M | 1 |
| Sugiyama, A | 1 |
1 other study available for candesartan and A-V Dissociation
| Article | Year |
|---|---|
In vivo electropharmacological effects of amiodarone and candesartan on atria of chronic atrioventricular block dogs.
Topics: Amiodarone; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Benzimidazoles | 2007 |